MeSH term
Frequency | Condition_Probility | Female | 50 | 0.0 |
Humans | 469 | 0.0 |
Pregnancy | 5 | 0.0 |
Animals | 281 | 0.0 |
1-Phosphatidylinositol 3-Kinase/physiology | 4 | 3.0 |
Cell Movement | 13 | 1.0 |
Mice | 134 | 0.0 |
Phosphoproteins/physiology | 2 | 3.0 |
Phosphorylation | 175 | 2.0 |
Protein-Tyrosine Kinase/*metabolism | 36 | 4.0 |
*Proteins | 9 | 2.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 37 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 222 | 0.0 |
Tumor Cells, Cultured | 73 | 0.0 |
src-Family Kinases/physiology | 4 | 12.0 |
Antineoplastic Agents/*pharmacology | 3 | 0.0 |
Apoptosis/drug effects | 2 | 0.0 |
Blotting, Northern | 15 | 0.0 |
Cadherins/*metabolism | 3 | 4.0 |
Calcium/metabolism | 12 | 0.0 |
Cell Adhesion/drug effects | 6 | 1.0 |
Cell Division/drug effects | 11 | 0.0 |
Cytoskeletal Proteins/*metabolism | 5 | 3.0 |
In Vitro | 14 | 0.0 |
Male | 46 | 0.0 |
Mice, SCID | 6 | 0.0 |
Pyrimidines/*pharmacology | 2 | 3.0 |
RNA, Messenger/metabolism | 9 | 0.0 |
Research Support, Non-U.S. Gov't | 353 | 0.0 |
src-Family Kinases/*antagonists & inhibitors | 5 | 31.0 |
Actins/physiology | 2 | 5.0 |
Intracellular Membranes/metabolism | 3 | 1.0 |
Molecular Sequence Data | 110 | 0.0 |
Phosphoproteins/*genetics/metabolism | 2 | 5.0 |
Proto-Oncogene Protein pp60(c-src)/metabolism | 7 | 17.0 |
Sequence Homology, Amino Acid | 31 | 0.0 |
Stress, Mechanical | 4 | 1.0 |
Tissue Distribution | 6 | 0.0 |
Tyrosine/metabolism | 55 | 4.0 |
*Adaptor Proteins, Signal Transducing | 55 | 4.0 |
Cell Nucleus/metabolism | 5 | 0.0 |
Cytoplasm/metabolism | 4 | 0.0 |
Macromolecular Substances | 16 | 0.0 |
Protein Transport | 3 | 0.0 |
Proteins/*chemistry/*metabolism | 3 | 9.0 |
RNA-Binding Proteins/*metabolism | 6 | 6.0 |
Rats | 72 | 0.0 |
Receptor, Insulin/*metabolism | 3 | 5.0 |
*Signal Transduction | 37 | 1.0 |
*src Homology Domains | 27 | 14.0 |
Blotting, Western | 42 | 0.0 |
Comparative Study | 29 | 0.0 |
Gene Expression Regulation | 8 | 0.0 |
Immunohistochemistry | 9 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Neuropeptides/*metabolism | 2 | 2.0 |
Phosphotyrosine/*metabolism | 5 | 8.0 |
Plasmids | 5 | 0.0 |
Precipitin Tests | 44 | 1.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Rats, Sprague-Dawley | 9 | 0.0 |
Rats, Wistar | 7 | 0.0 |
Receptors, Nerve Growth Factor/metabolism | 2 | 5.0 |
Reverse Transcriptase Polymerase Chain Reaction | 18 | 0.0 |
Signal Transduction | 87 | 1.0 |
Disease Models, Animal | 4 | 0.0 |
Enzyme Activation | 78 | 2.0 |
Jurkat Cells | 20 | 1.0 |
*MAP Kinase Signaling System | 2 | 1.0 |
Mice, Inbred C57BL | 8 | 0.0 |
Mitogen-Activated Protein Kinase 1/*metabolism | 3 | 2.0 |
Mitogen-Activated Protein Kinase 3 | 20 | 3.0 |
Mitogen-Activated Protein Kinases/*metabolism | 17 | 3.0 |
src-Family Kinases/metabolism | 30 | 16.0 |
ADP-ribosyl Cyclase | 3 | 0.0 |
Cell Division | 24 | 0.0 |
Cell Line | 118 | 0.0 |
Culture Media | 4 | 0.0 |
*Gene Transfer Techniques | 2 | 0.0 |
Kinetics | 30 | 0.0 |
Mice, Inbred NOD | 4 | 1.0 |
Time Factors | 30 | 0.0 |
*Transduction, Genetic | 2 | 2.0 |
3T3 Cells | 29 | 1.0 |
Culture Media, Serum-Free | 5 | 1.0 |
Fibroblasts | 3 | 0.0 |
Phosphotyrosine/metabolism | 23 | 5.0 |
Protein-Tyrosine Kinase/metabolism | 38 | 4.0 |
Recombinant Proteins/metabolism | 11 | 0.0 |
Transfection | 96 | 0.0 |
src-Family Kinases/*metabolism | 46 | 29.0 |
COS Cells | 30 | 1.0 |
Hela Cells | 20 | 0.0 |
Protein Binding | 69 | 0.0 |
Transcription, Genetic/physiology | 3 | 1.0 |
Adrenergic beta-Agonists/pharmacology | 2 | 4.0 |
Amino Acid Motifs | 5 | 0.0 |
CHO Cells | 10 | 0.0 |
Chimeric Proteins/metabolism | 3 | 1.0 |
Cyclic AMP/metabolism | 4 | 0.0 |
Hamsters | 11 | 0.0 |
Isoproterenol/pharmacology | 2 | 1.0 |
Microscopy, Confocal | 4 | 0.0 |
Mutation | 27 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 4 | 0.0 |
Proto-Oncogene Proteins/metabolism | 22 | 1.0 |
src Homology Domains/genetics | 3 | 5.0 |
Acetyltransferases/*metabolism | 2 | 2.0 |
Base Sequence | 44 | 0.0 |
Carrier Proteins/*metabolism | 6 | 0.0 |
DNA Primers | 14 | 0.0 |
Endoplasmic Reticulum/metabolism | 2 | 0.0 |
*Promoter Regions (Genetics) | 6 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Trans-Activators/*metabolism | 12 | 1.0 |
*Transcription Factors | 7 | 0.0 |
Amino Acid Sequence | 101 | 0.0 |
Calcium-Binding Proteins/*metabolism | 2 | 2.0 |
Membrane Proteins/metabolism | 4 | 0.0 |
Nerve Tissue Proteins/*metabolism | 5 | 1.0 |
Protein Interaction Mapping | 3 | 2.0 |
Protein Structure, Tertiary | 36 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 19 | 1.0 |
Recombinant Fusion Proteins/metabolism | 28 | 1.0 |
Sequence Homology | 2 | 0.0 |
*Ubiquitin-Protein Ligases | 6 | 1.0 |
Biological Transport | 5 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 25 | 2.0 |
Phosphoproteins/*metabolism | 14 | 3.0 |
Receptors, Fibroblast Growth Factor/metabolism | 4 | 8.0 |
Cell Adhesion/physiology | 4 | 1.0 |
Cell Line, Transformed | 9 | 0.0 |
Cytoskeletal Proteins/metabolism/physiology | 2 | 50.0 |
Proto-Oncogene Protein p21(ras)/metabolism | 3 | 3.0 |
*Trans-Activators | 5 | 0.0 |
src-Family Kinases/genetics/*metabolism | 6 | 28.0 |
Caspases/metabolism | 5 | 0.0 |
Cell Fractionation | 3 | 1.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
Gene Expression Regulation, Enzymologic | 3 | 0.0 |
Genes, Reporter | 15 | 0.0 |
Promoter Regions (Genetics) | 13 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 9 | 1.0 |
Tumor Necrosis Factor-alpha/metabolism | 2 | 0.0 |
Benzaldehydes/*pharmacology | 2 | 40.0 |
Cytoskeletal Proteins/metabolism | 9 | 3.0 |
Dose-Response Relationship, Drug | 22 | 0.0 |
Enzyme Inhibitors/pharmacology | 40 | 1.0 |
Epidermal Growth Factor/metabolism | 4 | 1.0 |
Immunoblotting | 11 | 0.0 |
Protein Binding/drug effects | 5 | 1.0 |
Amino Acid Substitution | 8 | 0.0 |
Catalysis | 7 | 0.0 |
Cell Transformation, Neoplastic | 5 | 0.0 |
*Drosophila Proteins | 3 | 0.0 |
Mutagenesis | 4 | 0.0 |
Polymerase Chain Reaction | 10 | 0.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 8 | 2.0 |
Receptor Protein-Tyrosine Kinases/genetics/*metabolism | 5 | 4.0 |
Models, Molecular | 17 | 0.0 |
Phosphoproteins/chemistry/metabolism | 2 | 8.0 |
Protons | 2 | 2.0 |
Cells, Cultured | 59 | 0.0 |
Chemotaxis/drug effects | 2 | 2.0 |
Enzyme Activation/drug effects | 14 | 1.0 |
Mice, Knockout | 13 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 13 | 3.0 |
Phosphorylation/drug effects | 21 | 2.0 |
Protein Binding/physiology | 7 | 2.0 |
Signal Transduction/physiology | 17 | 1.0 |
Tumor Necrosis Factor-alpha/pharmacology | 3 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 11 | 1.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors | 8 | 3.0 |
Trans-Activators/genetics/*physiology | 2 | 2.0 |
Cytoskeleton/*metabolism | 3 | 2.0 |
Substrate Specificity | 15 | 0.0 |
DNA-Binding Proteins/*metabolism | 9 | 0.0 |
Mutagenesis, Site-Directed | 30 | 1.0 |
*Proto-Oncogene Proteins | 12 | 0.0 |
Trans-Activation (Genetics) | 12 | 0.0 |
Transcription, Genetic | 14 | 0.0 |
Models, Biological | 26 | 0.0 |
Umbilical Veins/cytology | 4 | 1.0 |
Chick Embryo | 6 | 1.0 |
Kidney/cytology | 3 | 1.0 |
Neovascularization, Physiologic/physiology | 2 | 3.0 |
Protein-Tyrosine Kinase/chemistry/*metabolism | 2 | 5.0 |
Rabbits | 2 | 0.0 |
Signal Transduction/drug effects/*physiology | 4 | 1.0 |
Vascular Endothelial Growth Factor A | 4 | 0.0 |
Vascular Endothelial Growth Factors | 4 | 0.0 |
Androstadienes/pharmacology | 7 | 2.0 |
Flavonoids/pharmacology | 8 | 2.0 |
Protein-Tyrosine-Phosphatase/genetics/metabolism | 3 | 16.0 |
Pyrazoles/pharmacology | 4 | 8.0 |
Pyrimidines/pharmacology | 15 | 13.0 |
Quinones/pharmacology | 9 | 6.0 |
RNA, Messenger/genetics/metabolism | 7 | 0.0 |
Signal Transduction/drug effects | 8 | 1.0 |
Adult | 16 | 0.0 |
Aged | 10 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Middle Aged | 13 | 0.0 |
Receptors, Cell Surface/metabolism | 3 | 0.0 |
Survival Rate | 2 | 0.0 |
src Homology Domains/*physiology | 4 | 19.0 |
Cloning, Molecular | 36 | 0.0 |
DNA, Complementary | 5 | 0.0 |
Myristic Acid/metabolism | 2 | 8.0 |
RNA, Messenger/genetics | 7 | 0.0 |
Receptors, Antigen, T-Cell/*physiology | 6 | 3.0 |
Signal Transduction/*physiology | 17 | 1.0 |
English Abstract | 5 | 0.0 |
Receptor, Epidermal Growth Factor/*metabolism | 8 | 1.0 |
Casein Kinase II | 2 | 1.0 |
Clathrin/metabolism | 2 | 4.0 |
GTP-Binding Proteins/metabolism | 3 | 1.0 |
Glutathione Transferase/metabolism | 9 | 1.0 |
Microscopy, Fluorescence | 11 | 0.0 |
Plasmids/metabolism | 10 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Subcellular Fractions/metabolism | 3 | 0.0 |
Threonine/chemistry | 3 | 4.0 |
Adenocarcinoma | 3 | 2.0 |
Apoptosis/*drug effects | 4 | 0.0 |
*Cation Transport Proteins | 2 | 0.0 |
*DNA-Binding Proteins | 7 | 0.0 |
Electrophysiology | 2 | 0.0 |
Genistein/pharmacology | 8 | 7.0 |
Peptides/chemistry | 7 | 2.0 |
Phenols/pharmacology | 4 | 15.0 |
*Potassium Channels, Voltage-Gated | 2 | 0.0 |
Estrogen Receptor alpha | 6 | 2.0 |
Gene Expression Regulation/drug effects | 6 | 0.0 |
Receptors, Estrogen/*metabolism | 4 | 1.0 |
Transcription, Genetic/*drug effects | 2 | 0.0 |
Apoptosis/physiology | 3 | 0.0 |
Gene Expression Regulation, Neoplastic/physiology | 2 | 1.0 |
*MAP Kinase Kinase Kinase 1 | 3 | 2.0 |
Neoplasm Proteins/*physiology | 2 | 2.0 |
Proteasome Endopeptidase Complex | 3 | 0.0 |
Protein Kinases/physiology | 2 | 4.0 |
Proto-Oncogene Proteins/physiology | 2 | 1.0 |
Phosphotyrosine/physiology | 3 | 30.0 |
Protein Conformation | 16 | 0.0 |
Proto-Oncogene Protein pp60(c-src)/physiology | 4 | 50.0 |
Structure-Activity Relationship | 16 | 0.0 |
Mitogen-Activated Protein Kinase 1/antagonists & inhibitors/metabolism | 2 | 8.0 |
Peptide Fragments/pharmacology | 2 | 0.0 |
Signal Transduction/drug effects/physiology | 5 | 2.0 |
src-Family Kinases/antagonists & inhibitors/*metabolism | 6 | 35.0 |
*JNK Mitogen-Activated Protein Kinases | 3 | 3.0 |
Mitogen-Activated Protein Kinase 7 | 2 | 13.0 |
*Cell Cycle Proteins | 3 | 0.0 |
Cell Differentiation | 6 | 0.0 |
DNA, Neoplasm/biosynthesis | 2 | 1.0 |
MAP Kinase Signaling System/*physiology | 3 | 3.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 11 | 8.0 |
Protein Binding/immunology | 2 | 1.0 |
Vanadates/pharmacology | 5 | 3.0 |
Genes, Dominant | 3 | 0.0 |
Luciferases/metabolism | 7 | 1.0 |
Prostatic Neoplasms/metabolism | 2 | 3.0 |
Protein-Tyrosine Kinase/*physiology | 6 | 4.0 |
src-Family Kinases/*physiology | 10 | 25.0 |
Hematopoietic Stem Cells/*metabolism | 2 | 1.0 |
RNA, Messenger/biosynthesis | 6 | 0.0 |
Two-Hybrid System Techniques | 11 | 1.0 |
src Homology Domains | 65 | 11.0 |
Chromones/pharmacology | 3 | 1.0 |
Morpholines/pharmacology | 3 | 1.0 |
Phosphoproteins/*physiology | 3 | 3.0 |
Receptors, Endothelin/*metabolism | 2 | 33.0 |
*Apoptosis | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 8 | 2.0 |
Breast Neoplasms/*metabolism | 4 | 1.0 |
Cyclin D1/metabolism | 2 | 1.0 |
Enzyme Activation/drug effects/physiology | 2 | 3.0 |
Estradiol/*pharmacology | 3 | 1.0 |
Protein Subunits | 4 | 1.0 |
*Protein-Serine-Threonine Kinases | 14 | 1.0 |
Receptors, Estrogen/metabolism | 3 | 1.0 |
Apoptosis/*physiology | 2 | 0.0 |
Hydrogen Peroxide/pharmacology | 5 | 2.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
Oxidants/pharmacology | 3 | 4.0 |
Proto-Oncogene Proteins c-raf/metabolism | 2 | 2.0 |
Tyrphostins/pharmacology | 2 | 1.0 |
ras Proteins/metabolism | 5 | 3.0 |
Fibroblasts/metabolism | 8 | 0.0 |
Interleukin-6/*biosynthesis | 2 | 1.0 |
NIH 3T3 Cells | 8 | 2.0 |
Nuclear Proteins/metabolism | 4 | 0.0 |
Oncogene Proteins/metabolism | 4 | 5.0 |
Signal Transduction/immunology | 3 | 0.0 |
ras GTPase-Activating Proteins/metabolism | 2 | 15.0 |
Erythropoietin/*pharmacology | 2 | 1.0 |
Hematopoietic Stem Cells/metabolism | 3 | 2.0 |
*Milk Proteins | 5 | 1.0 |
Actins/*metabolism | 6 | 2.0 |
Phospholipids/metabolism | 3 | 1.0 |
Protein Kinase C/metabolism | 7 | 1.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/*metabolism | 3 | 4.0 |
Collagen/metabolism | 3 | 1.0 |
Drug Interactions | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 7 | 1.0 |
Tritium | 2 | 0.0 |
Drug Synergism | 3 | 0.0 |
Thrombin/*pharmacology | 4 | 3.0 |
Actins/metabolism | 6 | 1.0 |
Cell Adhesion Molecules/metabolism | 4 | 1.0 |
Dogs | 2 | 0.0 |
Endocytosis | 4 | 1.0 |
Fibronectins/metabolism | 7 | 3.0 |
Integrins/*metabolism | 4 | 2.0 |
Agar/metabolism | 2 | 40.0 |
Cell Nucleus/*metabolism | 3 | 0.0 |
Retroviridae/genetics | 4 | 1.0 |
Tetradecanoylphorbol Acetate/pharmacology | 8 | 0.0 |
*Transcription, Genetic | 7 | 0.0 |
Dimerization | 7 | 0.0 |
Transcription Factors/metabolism/*physiology | 2 | 2.0 |
DNA, Complementary/metabolism | 4 | 0.0 |
Proline/chemistry | 2 | 4.0 |
Proteins/metabolism | 18 | 1.0 |
Adherens Junctions/*physiology | 2 | 40.0 |
Cell Size | 2 | 0.0 |
Focal Adhesions/physiology | 2 | 33.0 |
Heterotrimeric GTP-Binding Proteins/metabolism | 2 | 5.0 |
rho GTP-Binding Proteins/metabolism | 2 | 2.0 |
Carrier Proteins/metabolism | 3 | 0.0 |
Down-Regulation | 10 | 0.0 |
Enzyme Precursors/*metabolism | 3 | 2.0 |
*Lectins, C-Type | 2 | 1.0 |
Phosphoproteins/metabolism | 22 | 3.0 |
Protein-Tyrosine-Phosphatase/metabolism | 6 | 4.0 |
Carrier Proteins/*physiology | 2 | 0.0 |
GTP Phosphohydrolases/metabolism | 2 | 1.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 2 | 1.0 |
Phosphoproteins/chemistry | 2 | 8.0 |
Pseudopodia/metabolism | 3 | 10.0 |
rhoA GTP-Binding Protein/metabolism | 2 | 2.0 |
Sequence Deletion | 12 | 0.0 |
Staurosporine/pharmacology | 3 | 1.0 |
Substrate Specificity/genetics | 2 | 4.0 |
Binding Sites/physiology | 2 | 1.0 |
Carrier Proteins/genetics/metabolism | 2 | 1.0 |
Cell Movement/physiology | 6 | 2.0 |
*Cytoskeletal Proteins | 4 | 3.0 |
Protein Kinase C/antagonists & inhibitors/metabolism | 4 | 4.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 18 | 3.0 |
Mice, Inbred Strains | 2 | 0.0 |
Receptor, Insulin/metabolism | 4 | 5.0 |
Carrier Proteins/biosynthesis/genetics | 2 | 5.0 |
Cell Division/drug effects/physiology | 2 | 0.0 |
Cell Line, Tumor | 28 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
Genes, myc | 3 | 1.0 |
Fibroblasts/cytology/metabolism | 4 | 2.0 |
Proto-Oncogene Proteins c-raf/genetics/*metabolism | 2 | 18.0 |
Detergents/pharmacology | 2 | 1.0 |
U937 Cells | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 7 | 0.0 |
Isoenzymes/metabolism | 4 | 0.0 |
MAP Kinase Signaling System/drug effects/*physiology | 2 | 5.0 |
Phospholipase C/metabolism | 8 | 2.0 |
Proteins/*metabolism | 13 | 1.0 |
Xenopus laevis | 3 | 0.0 |
Proto-Oncogene Proteins/genetics/metabolism | 5 | 2.0 |
Recombinant Fusion Proteins/genetics/metabolism | 8 | 0.0 |
src Homology Domains/physiology | 9 | 20.0 |
Lactones/pharmacology | 2 | 5.0 |
Microfilament Proteins/metabolism | 5 | 5.0 |
Signal Transduction/*drug effects | 4 | 1.0 |
src-Family Kinases/antagonists & inhibitors/*physiology | 3 | 60.0 |
Estrogen Receptor beta | 3 | 3.0 |
Ligands | 23 | 0.0 |
Nuclear Proteins/*metabolism | 9 | 1.0 |
Transcription Factors/*metabolism | 4 | 0.0 |
*Gene Amplification | 2 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
T-Lymphocytes/immunology/metabolism | 2 | 1.0 |
Microscopy, Electron | 3 | 0.0 |
Phenotype | 6 | 0.0 |
Cattle | 12 | 0.0 |
Insulin/*pharmacology | 5 | 2.0 |
*European Union | 2 | 40.0 |
*Health Policy | 2 | 5.0 |
*Health Priorities | 2 | 18.0 |
*Public Health | 2 | 18.0 |
Cell Division/physiology | 7 | 0.0 |
Gene Expression Regulation, Enzymologic/drug effects/physiology | 2 | 6.0 |
Insulin-Like Growth Factor II/*pharmacology | 2 | 15.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors/metabolism | 7 | 7.0 |
Up-Regulation | 7 | 0.0 |
DNA, Complementary/genetics | 7 | 0.0 |
Nerve Tissue Proteins/genetics/*metabolism | 3 | 2.0 |
Recombinant Fusion Proteins/isolation & purification/metabolism | 3 | 4.0 |
Antibodies, Monoclonal/pharmacology | 4 | 0.0 |
Cell Adhesion/*physiology | 4 | 3.0 |
Interleukin-8/pharmacology | 2 | 4.0 |
Protein Kinases/metabolism | 3 | 0.0 |
Binding Sites | 45 | 0.0 |
Carcinoma, Squamous Cell | 2 | 1.0 |
Cyclic AMP-Dependent Protein Kinases/*metabolism | 2 | 2.0 |
Green Fluorescent Proteins | 7 | 0.0 |
Phosphotyrosine | 12 | 4.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 7 | 5.0 |
Circular Dichroism | 3 | 0.0 |
Crystallography, X-Ray | 4 | 0.0 |
Nuclear Magnetic Resonance, Biomolecular | 2 | 1.0 |
Protein Structure, Secondary | 3 | 0.0 |
Protein-Tyrosine Kinase/*chemistry/metabolism | 2 | 16.0 |
Recombinant Proteins/chemistry/metabolism | 6 | 0.0 |
Mink | 2 | 3.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
T-Lymphocytes/*immunology | 6 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 7 | 0.0 |
Luminescent Proteins/genetics/metabolism | 3 | 1.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Trans-Activators/metabolism | 8 | 0.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
Gene Expression | 14 | 0.0 |
Phosphoproteins/genetics/*metabolism | 4 | 2.0 |
Protein Kinase C/*metabolism | 4 | 1.0 |
Protein-Tyrosine Kinase/biosynthesis/genetics/*metabolism | 2 | 28.0 |
Chickens | 5 | 0.0 |
Consensus Sequence | 3 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 6 | 0.0 |
src Homology Domains/*immunology | 2 | 14.0 |
*Adaptor Proteins, Vesicular Transport | 9 | 3.0 |
*Carrier Proteins | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 15 | 0.0 |
Gene Deletion | 2 | 0.0 |
Models, Genetic | 6 | 0.0 |
PC12 Cells | 6 | 1.0 |
Proteins/chemistry/*physiology | 2 | 9.0 |
Receptor, trkA/*metabolism | 2 | 40.0 |
Membrane Proteins/chemistry/*genetics | 2 | 3.0 |
Neoplasm Invasiveness | 4 | 0.0 |
Phosphoric Monoester Hydrolases/metabolism | 2 | 2.0 |
Plasmids/genetics | 2 | 0.0 |
Receptor, IGF Type 1/*metabolism | 2 | 5.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
Sequence Alignment | 14 | 0.0 |
Enzyme Inhibitors/*pharmacology | 6 | 0.0 |
*Nerve Tissue Proteins | 3 | 0.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors | 2 | 1.0 |
Receptors, Calcitriol/*metabolism | 2 | 2.0 |
Receptors, Cytoplasmic and Nuclear/*metabolism | 2 | 1.0 |
Alternative Splicing | 2 | 0.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
Exons | 4 | 0.0 |
Introns | 4 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
*Genes, src | 17 | 44.0 |
HT29 Cells | 3 | 1.0 |
Proto-Oncogene Protein pp60(c-src)/*genetics | 7 | 63.0 |
Genes, src/genetics/*physiology | 2 | 100.0 |
Mitogen-Activated Protein Kinases/genetics/*metabolism | 3 | 7.0 |
Receptor, Epidermal Growth Factor/genetics/*metabolism | 6 | 3.0 |
src-Family Kinases/antagonists & inhibitors/metabolism | 2 | 15.0 |
Signal Transduction/*immunology | 3 | 0.0 |
src Homology Domains/immunology | 2 | 7.0 |
Brain Chemistry | 2 | 0.0 |
Genes, Reporter/genetics | 2 | 0.0 |
Microinjections | 3 | 1.0 |
rac1 GTP-Binding Protein/metabolism | 2 | 2.0 |
Carrier Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
*Muscle Proteins | 2 | 0.0 |
Antineoplastic Agents/pharmacology | 5 | 0.0 |
Chemotaxis | 3 | 1.0 |
DNA/biosynthesis | 3 | 0.0 |
Flow Cytometry | 12 | 0.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors/*metabolism | 2 | 2.0 |
Cell Movement/*physiology | 6 | 2.0 |
Proto-Oncogene Protein pp60(c-src)/genetics/*metabolism | 5 | 45.0 |
Receptors, Vitronectin/*metabolism | 2 | 10.0 |
Transcription Factors/metabolism | 7 | 0.0 |
Tyrosine | 5 | 4.0 |
Binding Sites/genetics | 5 | 0.0 |
Integrins/metabolism | 4 | 2.0 |
Interleukin-2/metabolism | 2 | 1.0 |
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/*metabolism | 5 | 12.0 |
Cell Nucleus/enzymology | 2 | 2.0 |
Genes, src | 6 | 26.0 |
Subcellular Fractions/enzymology | 2 | 2.0 |
Chloramphenicol O-Acetyltransferase/genetics/metabolism | 2 | 1.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Genes, src/*genetics | 3 | 30.0 |
*Caenorhabditis elegans Proteins | 3 | 2.0 |
Molecular Structure | 3 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
Protein-Serine-Threonine Kinases/antagonists & inhibitors/metabolism | 2 | 2.0 |
src-Family Kinases/genetics/metabolism | 3 | 23.0 |
Hepatocyte Growth Factor/*metabolism | 2 | 1.0 |
Phosphoric Monoester Hydrolases/*metabolism | 4 | 4.0 |
Proto-Oncogene Protein c-kit/metabolism | 2 | 4.0 |
Proto-Oncogene Proteins/chemistry/*metabolism | 3 | 5.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 5 | 1.0 |
Receptors, Antigen, B-Cell/*metabolism | 2 | 2.0 |
Receptors, Collagen | 2 | 2.0 |
Estradiol/pharmacology | 2 | 0.0 |
Alleles | 2 | 0.0 |
Oncogenes | 2 | 0.0 |
Peptide Fragments/metabolism | 2 | 0.0 |
Protein Processing, Post-Translational | 4 | 0.0 |
DNA | 5 | 0.0 |
*Nuclear Proteins | 4 | 0.0 |
*Caveolins | 2 | 5.0 |
Cell Membrane/physiology/ultrastructure | 2 | 8.0 |
GTP-Binding Protein alpha Subunits, Gi-Go/*metabolism | 3 | 15.0 |
Virulence Factors, Bordetella/pharmacology | 2 | 1.0 |
Insulin/pharmacology | 2 | 0.0 |
Transcription, Genetic/drug effects | 4 | 0.0 |
Genes, src/*physiology | 2 | 25.0 |
*Repressor Proteins | 5 | 0.0 |
Protein-Tyrosine-Phosphatase/antagonists & inhibitors | 2 | 5.0 |
src-Family Kinases/antagonists & inhibitors | 4 | 20.0 |
Fluorescent Antibody Technique | 5 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Protein-Tyrosine Kinase/*genetics/metabolism | 2 | 4.0 |
Crotalid Venoms/pharmacology | 2 | 5.0 |
Cytoskeleton/metabolism | 3 | 1.0 |
Platelet Aggregation/drug effects | 3 | 1.0 |
Cross-Linking Reagents/pharmacology | 3 | 2.0 |
Enzyme Precursors/metabolism | 4 | 2.0 |
Molecular Weight | 9 | 0.0 |
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 1.0 |
Cell Adhesion | 7 | 0.0 |
Drug Combinations | 2 | 0.0 |
Tyrosine/*metabolism | 10 | 3.0 |
DNA Primers/genetics | 2 | 0.0 |
*Mutation | 8 | 0.0 |
Neoplasm Staging | 3 | 0.0 |
Calcium/physiology | 3 | 1.0 |
Integrins/*physiology | 4 | 4.0 |
Protein-Tyrosine-Phosphatase/*physiology | 3 | 11.0 |
Cell Cycle | 3 | 0.0 |
Neoplasms/metabolism | 2 | 2.0 |
Retinoblastoma Protein/metabolism | 2 | 0.0 |
Proteins/*genetics | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Receptor, Epidermal Growth Factor/metabolism | 11 | 1.0 |
DNA/metabolism | 4 | 0.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
HL-60 Cells | 2 | 0.0 |
Protein Binding/radiation effects | 2 | 18.0 |
Protein-Tyrosine Kinase/physiology | 4 | 3.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 2 | 0.0 |
Reactive Oxygen Species/*metabolism | 3 | 1.0 |
Schizosaccharomyces/genetics | 2 | 4.0 |
Oxidation-Reduction | 3 | 0.0 |
Serotonin/pharmacology | 2 | 7.0 |
Receptors, Steroid/*metabolism | 2 | 3.0 |
Fungal Proteins/metabolism | 2 | 1.0 |
Saccharomyces cerevisiae | 4 | 1.0 |
Catalytic Domain | 5 | 1.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Colonic Neoplasms | 2 | 1.0 |
DNA-Binding Proteins/metabolism | 7 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
Transcription Factor, Sp1/*metabolism | 2 | 0.0 |
B-Lymphocytes/cytology | 2 | 2.0 |
Cell Culture Techniques/methods | 2 | 0.0 |
*Hematopoietic Stem Cell Transplantation | 3 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Recombinant Proteins/biosynthesis | 2 | 0.0 |
Cell Division/genetics | 3 | 0.0 |
Cell Transformation, Neoplastic/*genetics | 2 | 1.0 |
Neoplasm Metastasis | 5 | 0.0 |
Genes, Tumor Suppressor | 3 | 0.0 |
CD4-Positive T-Lymphocytes/drug effects/*metabolism | 2 | 20.0 |
Calcineurin/metabolism | 2 | 8.0 |
Calmodulin/metabolism | 2 | 4.0 |
NF-kappa B/*metabolism | 3 | 0.0 |
Phytohemagglutinins/pharmacology | 2 | 0.0 |
Vanadium Compounds/*antagonists & inhibitors | 2 | 100.0 |
Isoenzymes/*metabolism | 4 | 1.0 |
Phospholipase C/*metabolism | 4 | 3.0 |
Platelet-Derived Growth Factor/*pharmacology | 4 | 4.0 |
Proto-Oncogene Protein pp60(c-src)/antagonists & inhibitors/*metabolism | 2 | 40.0 |
Receptor, Platelet-Derived Growth Factor beta/*metabolism | 2 | 66.0 |
Brain/metabolism | 3 | 0.0 |
Escherichia coli | 3 | 0.0 |
Oncogene Protein pp60(v-src)/metabolism | 2 | 25.0 |
Proline/metabolism | 2 | 3.0 |
Organ Specificity | 5 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Point Mutation | 8 | 0.0 |
Proto-Oncogene Proteins/chemistry/genetics/*metabolism | 3 | 5.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 6 | 2.0 |
Receptor, Platelet-Derived Growth Factor beta/metabolism | 2 | 16.0 |
*Protein Processing, Post-Translational | 2 | 0.0 |
Cell Membrane/metabolism | 8 | 0.0 |
Cytosol/metabolism | 2 | 0.0 |
Mice, Nude | 9 | 0.0 |
Neoplasm Transplantation | 4 | 0.0 |
Cytokines/*metabolism | 2 | 0.0 |
Proteins/genetics/metabolism | 2 | 1.0 |
Computational Biology | 2 | 1.0 |
Protein-Tyrosine Kinase | 2 | 5.0 |
Neurons/*physiology | 2 | 1.0 |
Receptors, N-Methyl-D-Aspartate/*physiology | 2 | 33.0 |
Platelet-Derived Growth Factor/pharmacology | 3 | 1.0 |
*Gene Expression Regulation | 8 | 0.0 |
Urinary Plasminogen Activator/*metabolism | 3 | 8.0 |
Acetyltransferases/metabolism | 2 | 2.0 |
Prostate/metabolism | 2 | 2.0 |
Gene Library | 3 | 0.0 |
Cell Survival/drug effects | 7 | 0.0 |
Genes, ras | 3 | 1.0 |
S Phase | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 3 | 0.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Lymphocyte Activation | 3 | 0.0 |
Pedigree | 3 | 0.0 |
Calcium/*metabolism | 2 | 0.0 |
Cell Differentiation/physiology | 2 | 0.0 |
*Cell Transformation, Neoplastic | 5 | 1.0 |
Receptor Aggregation | 2 | 2.0 |
Receptors, Antigen, T-Cell/*metabolism | 5 | 3.0 |
*Proto-Oncogenes | 7 | 1.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors | 2 | 2.0 |
*DNA Damage | 2 | 0.0 |
Epidermal Growth Factor/pharmacology | 5 | 0.0 |
Peptide Mapping | 4 | 0.0 |
Trypsin | 3 | 1.0 |
Colonic Neoplasms/*genetics | 2 | 2.0 |
Mice, Inbred BALB C | 5 | 0.0 |
Mutation/genetics | 5 | 0.0 |
Apoptosis | 11 | 0.0 |
Cell Adhesion Molecules/metabolism/*physiology | 2 | 25.0 |
Protein-Tyrosine Kinase/metabolism/*physiology | 2 | 7.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Mitogen-Activated Protein Kinases/physiology | 3 | 2.0 |
Recombinant Fusion Proteins/chemistry/genetics/metabolism | 2 | 1.0 |
Endothelium, Vascular/metabolism | 2 | 0.0 |
MAP Kinase Signaling System | 6 | 2.0 |
Neutrophils/metabolism | 2 | 1.0 |
Phosphoprotein Phosphatase/metabolism | 2 | 2.0 |
Proto-Oncogene Protein pp60(c-src)/*metabolism | 12 | 30.0 |
Proteins/genetics/*metabolism | 4 | 0.0 |
ras Guanine Nucleotide Exchange Factors | 2 | 3.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology | 2 | 1.0 |
Genome | 3 | 1.0 |
Oncogene Protein pp60(v-src)/*metabolism | 5 | 41.0 |
Receptor Protein-Tyrosine Kinases/metabolism | 6 | 2.0 |
GTP-Binding Proteins/*metabolism | 3 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
Guanine Nucleotide Exchange Factors | 4 | 4.0 |
Protein Binding/genetics | 2 | 0.0 |
Proteins/*chemistry/genetics | 2 | 9.0 |
Receptors, Platelet-Derived Growth Factor/metabolism | 3 | 6.0 |
DNA/genetics | 3 | 0.0 |
Gene Expression/drug effects | 2 | 0.0 |
Transcription Factor AP-1/metabolism | 2 | 0.0 |
Antibodies/pharmacology | 4 | 1.0 |
Cyclic AMP-Dependent Protein Kinases/metabolism | 3 | 1.0 |
Cercopithecus aethiops | 4 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
Promoter Regions (Genetics)/genetics | 3 | 0.0 |
Proteins/isolation & purification/*metabolism | 2 | 6.0 |
Spodoptera | 4 | 1.0 |
G0 Phase | 2 | 2.0 |
G1 Phase | 2 | 0.0 |
Peptides/*metabolism | 2 | 1.0 |
Breast Neoplasms | 2 | 0.0 |
Cell Extracts | 2 | 1.0 |
Receptors, Erythropoietin/*metabolism | 2 | 11.0 |
Receptor, trkA | 2 | 3.0 |
Antigens, CD3/*metabolism | 2 | 4.0 |
Immunologic Capping | 2 | 4.0 |
Conserved Sequence | 2 | 0.0 |
Cytosol/enzymology | 2 | 1.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 2 | 1.0 |
Breast Neoplasms/metabolism | 3 | 2.0 |
Cell Survival | 5 | 0.0 |
*Depsipeptides | 2 | 6.0 |
Fibroblasts/cytology/drug effects/metabolism | 2 | 3.0 |
*RNA Splicing | 3 | 1.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Cell Membrane/enzymology | 3 | 1.0 |
Recombinant Fusion Proteins/biosynthesis/metabolism | 2 | 2.0 |
Epidermal Growth Factor/*pharmacology | 5 | 0.0 |
Kidney | 4 | 1.0 |
T-Lymphocytes/*metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/biosynthesis/*metabolism | 2 | 18.0 |
Proto-Oncogene Proteins c-raf | 2 | 1.0 |
Chemotaxis/drug effects/*physiology | 2 | 13.0 |
Proto-Oncogene Protein pp60(c-src)/immunology/*metabolism | 2 | 100.0 |
Erythropoietin, Recombinant/*pharmacology | 2 | 8.0 |
Prognosis | 2 | 0.0 |
Retinoblastoma Protein/*metabolism | 2 | 1.0 |
Tumor Markers, Biological/*metabolism | 2 | 0.0 |
Adolescent | 5 | 0.0 |
Child | 5 | 0.0 |
Child, Preschool | 3 | 0.0 |
Heterozygote Detection | 3 | 0.0 |
*Linkage (Genetics) | 3 | 0.0 |
Protein-Tyrosine Kinase/*genetics | 4 | 1.0 |
Blotting, Southern | 3 | 0.0 |
Cell Separation | 3 | 0.0 |
Models, Structural | 2 | 1.0 |
*Protein Structure, Secondary | 2 | 1.0 |
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 7 | 3.0 |
Octoxynol | 2 | 3.0 |
Oncogene Protein pp60(v-src)/genetics/metabolism | 2 | 50.0 |
Solubility | 2 | 0.0 |
Receptors, Antigen, B-Cell/*physiology | 2 | 2.0 |
*src-Family Kinases | 6 | 14.0 |
Protein Kinases/*metabolism | 2 | 0.0 |
Serine/metabolism | 4 | 1.0 |
Swine | 3 | 0.0 |
Agammaglobulinemia/*genetics | 3 | 8.0 |
Infant | 3 | 0.0 |
*X Chromosome | 4 | 0.0 |
*Lymphocyte Activation | 3 | 0.0 |
Protein-Tyrosine-Phosphatase/genetics/*metabolism | 3 | 6.0 |
RNA, Small Interfering/genetics | 3 | 2.0 |
Breast Neoplasms/enzymology/*metabolism/pathology | 2 | 22.0 |
Nitric-Oxide Synthase/*metabolism | 2 | 2.0 |
Colony-Forming Units Assay | 2 | 0.0 |
Gene Amplification | 2 | 0.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
Receptor, erbB-2/metabolism | 2 | 1.0 |
United States | 2 | 0.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
Trypsin/metabolism | 2 | 1.0 |
Phosphotransferases/metabolism | 4 | 8.0 |
MAP Kinase Signaling System/physiology | 3 | 3.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Integrin alphaVbeta3/*metabolism | 2 | 20.0 |
3T3-L1 Cells | 2 | 8.0 |
Estradiol/*metabolism | 2 | 3.0 |
Mitogen-Activated Protein Kinase 1 | 3 | 2.0 |
Receptors, Estradiol/*metabolism | 2 | 18.0 |
Proto-Oncogene Protein c-kit/*metabolism | 3 | 6.0 |
Umbilical Veins | 2 | 0.0 |
src-Family Kinases/antagonists & inhibitors/metabolism/*physiology | 2 | 66.0 |
Sequence Analysis | 2 | 0.0 |
Magnetic Resonance Spectroscopy | 3 | 0.0 |
Neurons/*metabolism | 2 | 0.0 |
Antigens, CD/metabolism | 3 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Cell Transformation, Neoplastic/genetics | 2 | 0.0 |
GTPase-Activating Proteins | 5 | 3.0 |
ras GTPase-Activating Proteins | 6 | 5.0 |
Cell Membrane/*metabolism | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase | 8 | 5.0 |
Phosphotransferases (Alcohol Group Acceptor)/*metabolism | 2 | 2.0 |
Lymphocyte Activation/*immunology | 2 | 0.0 |
Protein Isoforms/physiology | 2 | 5.0 |
Protein-Tyrosine Kinase/isolation & purification/*metabolism | 2 | 10.0 |
Receptors, Antigen, T-Cell/*immunology | 2 | 1.0 |
Tyrosine/analogs & derivatives/analysis | 2 | 5.0 |
Oligodeoxyribonucleotides | 3 | 0.0 |
Protein Structure, Tertiary/physiology | 2 | 1.0 |
Phosphoproteins/isolation & purification/*metabolism | 2 | 6.0 |
Tyrosine/*analogs & derivatives/metabolism | 2 | 3.0 |
Peptide Fragments/chemistry/metabolism | 3 | 2.0 |
Protein-Tyrosine Kinase/*chemistry/*metabolism | 2 | 13.0 |
Hematopoietic Stem Cells/physiology | 3 | 7.0 |
Genetic Vectors | 7 | 0.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Phosphoproteins/isolation & purification/metabolism | 2 | 5.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/*metabolism | 2 | 3.0 |
*Cell Transformation, Viral | 2 | 1.0 |
Tyrosine/analogs & derivatives/metabolism | 3 | 2.0 |
Chromosome Deletion | 2 | 0.0 |
Peptides/chemistry/metabolism | 2 | 4.0 |
Phosphotransferases (Alcohol Group Acceptor)/metabolism | 2 | 2.0 |
Collagen/*metabolism | 2 | 1.0 |
Hydrogen Bonding | 2 | 1.0 |
Poly(ADP-ribose) Polymerases/metabolism | 2 | 1.0 |
Pressure | 2 | 1.0 |
Protein-Tyrosine Kinase/chemistry/metabolism | 3 | 18.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Thrombin/pharmacology | 2 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/genetics/*metabolism | 2 | 22.0 |
Recombinant Proteins/pharmacology | 4 | 0.0 |
Receptor, Insulin/genetics/*metabolism | 2 | 15.0 |
Proto-Oncogene Protein c-met | 2 | 1.0 |
Antigens, CD34/metabolism | 2 | 0.0 |
Tyrosine/chemistry | 6 | 4.0 |
Insects | 2 | 1.0 |
Endothelium, Vascular/cytology | 2 | 0.0 |
Caco-2 Cells | 2 | 0.0 |
Cell Communication | 2 | 0.0 |
Serine/chemistry | 2 | 1.0 |
Methotrexate/administration & dosage | 2 | 2.0 |
Retrospective Studies | 3 | 0.0 |
Phosphopeptides/isolation & purification | 2 | 11.0 |
*Tyrosine | 2 | 4.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Vascular Endothelial Growth Factor A/*pharmacology | 3 | 7.0 |
Acylation | 2 | 2.0 |
Chromatography, Ion Exchange | 2 | 0.0 |
*Oncogenes | 6 | 1.0 |
Endothelium, Vascular/*cytology/metabolism | 2 | 3.0 |
Pertussis Toxin/pharmacology | 2 | 3.0 |
Cell Movement/drug effects | 2 | 0.0 |
Age Factors | 2 | 0.0 |
Adenoviridae/genetics | 3 | 0.0 |
Endothelium, Vascular/*metabolism | 2 | 0.0 |
Enzyme Activation/physiology | 3 | 1.0 |
Nitric Oxide/metabolism | 2 | 1.0 |
Receptor Cross-Talk | 2 | 5.0 |
Pyrazoles/*pharmacology | 2 | 18.0 |
Recombinant Proteins/genetics/metabolism | 4 | 0.0 |
Receptors, Androgen/*metabolism | 2 | 1.0 |
Phosphoric Monoester Hydrolases/genetics/*metabolism | 2 | 4.0 |
Endothelium, Vascular/drug effects/metabolism | 2 | 3.0 |
Protein Isoforms | 2 | 0.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 3 | 0.0 |
Antigens, CD29/metabolism | 2 | 3.0 |
Ultraviolet Rays | 2 | 0.0 |
Integrin alpha2beta1/*metabolism | 2 | 33.0 |
Endothelium, Vascular/cytology/metabolism | 2 | 1.0 |
Focal Adhesions/*physiology | 2 | 40.0 |
Kidney/cytology/metabolism | 2 | 2.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
Cytochalasin D/pharmacology | 2 | 2.0 |
